Crossmark

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Crossref DOI link: https://doi.org/10.1007/s12325-022-02212-3

Published Online: 2022-06-25

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fulcher, Gregory R. http://orcid.org/0000-0001-8782-0420
Akhtar, Shahid

Al-Jaser, Saleh J.

Medina, Johan

Mohamed, Mafauzy

Nicodemus, Nemencio A. Jr

Olsen, Anne Helene

Singh, Kiran P.

Kok, Adri
Funding

Funding for this research was provided by:

Novo Nordisk

University of Sydney
License Information

Text and Data Mining valid from 2022-06-25

Version of Record valid from 2022-06-25
More Information

Article History

Received: 15 March 2022

Accepted: 31 May 2022

First Online: 25 June 2022

Change Date: 31 October 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12325-022-02349-1

Updates are available Correction dated 2022-10-31

Click to view Correction: https://doi.org/10.1007/s12325-022-02349-1